Ronald Blue Trust, Inc. Cure Vac N.V. Transaction History

Ronald Blue Trust, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$2.49 - $3.41 $3,844 - $5,265	1,544 Added 43.35%	5,106 $17,000
Q3 2024 Oct 17, 2024	BUY	$2.74 - $3.79 $9,518 - $13,166	3,474 Added 3947.73%	3,562 $10,000
Q2 2024 Jul 18, 2024	BUY	$2.31 - $4.99 $203 - $439	88 New	88 $0
Q4 2023 Jan 18, 2024	BUY	$3.96 - $6.41 $281 - $455	71 New	71 $0
Q2 2023 Jul 14, 2023	BUY	$6.69 - $12.25 $40 - $73	6 New	6 $0
Q4 2022 Jan 17, 2023	BUY	$5.75 - $8.5 $368 - $544	64 Added 152.38%	106 $1,000
Q3 2022 Oct 21, 2022	BUY	$7.48 - $15.24 $314 - $640	42 New	42 $1,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.